Status
Conditions
Treatments
About
To assess a 15-day wear period of the Cascade Continuous Glucose Monitoring (CGM) System
Full description
To assess a 15-day wear period for the Cascade CGM. The study wear period includes four in-clinic days in which frequent blood draws and Yellow Springs Instrument (YSI) glucose measurements will be performed. Participants will be blinded to CGM glucose values during the study. A retrospective performance assessment will be conducted following the study.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
10 participants in 1 patient group
Loading...
Central trial contact
Mihailo V. Rebec, PhD; Ellen M Anderson, MPH
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal